Charles Schwab’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-60,952
| Closed | -$138K | – | 3632 |
|
|
2024
Q1 | $138K | Sell |
60,952
-11,791
| -16% | -$26.8K | ﹤0.01% | 3277 |
|
|
2023
Q4 | $213K | Hold |
72,743
| – | – | ﹤0.01% | 3270 |
|
|
2023
Q3 | $308K | Hold |
72,743
| – | – | ﹤0.01% | 3206 |
|
|
2023
Q2 | $638K | Buy |
+72,743
| New | +$638K | ﹤0.01% | 2937 |
|
|
2023
Q1 | – | Sell |
-3,395
| Closed | -$41.4K | – | 3556 |
|
|
2022
Q4 | $41.4K | Hold |
3,395
| – | – | ﹤0.01% | 3397 |
|
|
2022
Q3 | $29K | Hold |
3,395
| – | – | ﹤0.01% | 3438 |
|
|
2022
Q2 | $56K | Sell |
3,395
-22,389
| -87% | -$369K | ﹤0.01% | 3378 |
|
|
2022
Q1 | $311K | Hold |
25,784
| – | – | ﹤0.01% | 3208 |
|
|
2021
Q4 | $421K | Buy |
25,784
+1,507
| +6% | +$24.6K | ﹤0.01% | 3199 |
|
|
2021
Q3 | $386K | Buy |
24,277
+2,758
| +13% | +$43.9K | ﹤0.01% | 3212 |
|
|
2021
Q2 | $1.99M | Buy |
21,519
+18,701
| +664% | +$1.73M | ﹤0.01% | 2714 |
|
|
2021
Q1 | $147K | Hold |
2,818
| – | – | ﹤0.01% | 3351 |
|
|
2020
Q4 | $77K | Buy |
2,818
+2,268
| +412% | +$62K | ﹤0.01% | 3332 |
|
|
2020
Q3 | $16K | Hold |
550
| – | – | ﹤0.01% | 3322 |
|
|
2020
Q2 | $8K | Hold |
550
| – | – | ﹤0.01% | 3315 |
|
|
2020
Q1 | $7K | Hold |
550
| – | – | ﹤0.01% | 3221 |
|
|
2019
Q4 | $12K | Hold |
550
| – | – | ﹤0.01% | 3168 |
|
|
2019
Q3 | $13K | Hold |
550
| – | – | ﹤0.01% | 3167 |
|
|
2019
Q2 | $17K | Sell |
550
-1,868
| -77% | -$57.7K | ﹤0.01% | 3205 |
|
|
2019
Q1 | $50K | Buy |
+2,418
| New | +$50K | ﹤0.01% | 3125 |
|